publication venue for
- Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' reply.. 58:962-963. 2023
- Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort study.. 58:715-724. 2023
- Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding.. 57:94-102. 2022
- Letter: fighting the battle but losing the war-inflammatory bowel disease and venous thromboembolism. Authors' reply.. 56:1427-1428. 2022
- Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply.. 56:1213-1214. 2022
- Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.. 56:1157-1167. 2022
- Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes.. 55:1459-1460. 2022
- Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases.. 52:311-318. 2020
- Review article: impact of exercise on physical frailty in patients with chronic liver disease.. 50:988-1000. 2019
- Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.. 49:1518-1527. 2019
- Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.. 49:564-571. 2019
- Meta-analysis: probiotics in antibiotic-associated diarrhoea.. 35:1355-69. 2012
- Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis.. 21:1099-104. 2005